Normal saline injection; a promising method to treat steroid-induced atrophy
Authors
Abstract:
Subcutaneous fat atrophy at the site of multiple injections can follow intradermal or intramuscular administration of steroids to treat inflammatory diseases. This condition takes several months to develop, and usually patients seek medical attention due to cosmetic deformities. Several methods, including fat transfer, filler injection and normal saline injection haven been proposed to treat steroid-induced atrophy. However, no standard procedure has been established for normal saline injection in terms of quantity and time interval between sessions. Normal injectable saline was administered every other week for 3 months, followed by 3 months’ rest. During follow-up, the response was satisfactory. As far as the authors are aware, this is the first demonstration of this method’s applicability to cases of steroid-induced atrophy in pediatric settings.
similar resources
Treatment of local, persistent cutaneous atrophy following corticosteroid injection with normal saline infiltration.
BACKGROUND Injections of corticosteroids are commonly used for a variety a dermatologic conditions but may cause local, persistent cutaneous atrophy, with few therapeutic options. OBJECTIVE To determine the effectiveness of bacteriostatic normal saline infiltration on the improvement of corticosteroid-induced cutaneous atrophy. MATERIALS AND METHODS Four patients with corticosteroid-induced...
full textGluteal Subcutaneous Atrophy After Depot Steroid Injection for Allergic Rhinitis
: Allergic rhinitis is a common and often distressing condition. Currently, treatment with nonsedating antihistamines, topical therapy, and immunotherapy are very effective. Despite this, intramuscular depot steroids are commonly used in clinical practice. Here, we present the case of a young woman who developed disfiguring scarring after a depot steroid injection. This case highlights the risk...
full textIntravitreal Injection of Bevacizumab (Avastin) to Treat Posterior Capsule Neovascularization
We report a 64-year-old diabetic woman who developed neovascularization of the posterior capsule 2 years after cataract surgery and intraocular lens implantation. The patient was treated with single injection of 1.25 mg of intravitreal bevacizumab (Avastin) via pars plana. After one week, complete regression of the posterior capsule neovascularization was achieved allowing us to perform Nd: YAG...
full textAccidental digital epinephrine injection: to treat or not to treat?
Epinephrine autoinjectors are widely prescribed for the self-treatment of anaphylaxis. Accidental digital injection of epinephrine is an increasingly common occurrence and can be associated with profound ischemia of the affected digit. Several case reports of such injuries exist; however, it is unclear what the appropriate treatment of accidental digital epinephrine injection should be. We will...
full textEfficacy of Adjuvant 10% Hypertonic Saline in Transforaminal Epidural Steroid Injection: A Retrospective Analysis.
BACKGROUND Chronic lower back pain with or without radiculopathy represents an important medical, social, and economic problem. Many treatment modalities and techniques, including surgery and epidural administration of steroids, have been used to manage this pain. Hypertonic saline, which has been used as an adjunct to percutaneous epidural adhesiolysis, can also be injected via a transforamina...
full textSteroid-induced ocular hypertension in normal sheep.
PURPOSE To determine whether the ovine eye develops elevation of intraocular pressure (IOP) in response to corticosteroid applied topically. METHODS IOP was monitored by Perkins applanation tonometry in a group of 18 sheep receiving topically administered 0.5% prednisolone acetate in one eye (experimental), three times daily, for a period of 3 or four 4 weeks after the establishment of baseli...
full textMy Resources
Journal title
volume 21 issue 1
pages 20- 22
publication date 2018-01-01
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023